USA - NASDAQ:NAKA - US49457M1062 - Common Stock
We assign a fundamental rating of 3 out of 10 to NAKA. NAKA was compared to 101 industry peers in the Health Care Providers & Services industry. While NAKA has a great health rating, there are worries on its profitability. NAKA does not seem to be growing, but still is valued expensively.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -55.28% | ||
ROE | -60.97% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 98.73% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Altman-Z | 283.48 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 12.99 | ||
Quick Ratio | 12.99 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:NAKA (9/30/2025, 1:47:09 PM)
1.075
-0.09 (-8.12%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 180.52 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 45.09 | ||
P/tB | 66.33 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -55.28% | ||
ROE | -60.97% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 98.73% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 2456.96% | ||
Cap/Sales | 129.98% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 12.99 | ||
Quick Ratio | 12.99 | ||
Altman-Z | 283.48 |